FAP and neoplasm: It is hypothesized that FAPI-RGD would not only confer extra tumor specificity over other diseases, which is rationalized by the expression of both FAP and integrin αvβ3 in a variety of tumors; but also outperform its monomeric counterparts, with regard to tumor uptake and tumor retention.